Japan headquartered Kyowa Kirin has announced that the U.S. Food and Drug Administration (FDA) has granted approval for ...
Invicro , a member of the Konica Minolta Group and a leading provider of biomarkers for imaging, core lab services and s...
Japan based pharmaceutical firm Eisai Co., Ltd. announced that it provides tanks to supply clean water for the neglected...
Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENTTe...
Atonarp, a Japan headquartered hi-tech molecular diagnostics company, has announced that it has raised $33 million&...
Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hy...
GSK has announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare...
Takeda Pharmaceutical Company Limited has submitted a New Drug Application (NDA) to the Ministry of Health, Labour and W...
The Biological Systems Engineering Lab at Hiroshima University, Japan has developed a new 3D printed prosthetic hand com...
Shimadzu Medical Systems, a subsidiary of Shimadzu Corporation Japan, is proud to announce that they have received FDA 5...
OssDsign AB (publ), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a ...
Eisai Co., Ltd. has announced that it refresh its SAHNE® CREAM (quasi-drug) which has been widely used as medic...
Japan based Astellas Pharma Inc. has announced dosing of the first patient in the SKYLIGHT 1™ Phase 3 pivotal tria...
POLA Chemical Industries, Inc. Frontier Research Center (FRC) of POLA ORBIS Holdings Inc. and one of the world's top res...
Daiichi Sankyo Company has announced that the U.S. Food and Drug Administration (FDA) approved TURALIO™(pexidartin...
Sosei Group Corporation has announced that it has entered into a strategic multi-target partnership with Takeda Pharmace...
Rakuten Medical, Inc., a clinical-stage, global biotechnology company developing precision-targeted cancer therapies bas...
Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM™ RAS CRC Kit, ...
